| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 10/23/2008 | US20080263685 Transgenic non-human animal expressing metabotropic glutamate receptor 1 in a melanocyte-specific manner for identifying modulators for prevention and treatment of cell proliferative disorders |
| 10/23/2008 | US20080262211 Hepatitis-c virus type 4, 5 and 6 |
| 10/23/2008 | US20080262204 A purified affinity-matured antibody or a portion thereof having binding specificity for 83 kDa protective antigen (PA83) of Bacillus anthracis; confers protection to a host against a tripartite toxin of Bacillus anthracis; cloned from an anti-Bacillus anthracis PA83 hybridoma |
| 10/23/2008 | US20080262203 Novel compounds |
| 10/23/2008 | US20080261877 Albumin Fusion Proteins |
| 10/23/2008 | US20080261833 Methods for generating polynucleotides having desired characteristics by iterative selection and recombination |
| 10/23/2008 | US20080261302 Nucleotide sequences coding seladin-1polypeptide for use in treatment and prevention of alzheimer's disease |
| 10/23/2008 | US20080261301 Mammalian cell demonstrating GDP-mannose 4,6-dehydratase (GMD) suppression and which expresses immunoglobulin associated with antibody-dependent cellular cytotoxicity; targeted treatment of tumors |
| 10/23/2008 | US20080261257 Fluorescent Proteins and Related Methods and Compounds |
| 10/23/2008 | US20080261252 Soluble Interleukin-1 Receptor Accessory Molecule |
| 10/23/2008 | US20080261251 Monoclonal Antibodies, Hybridomas, Improved Method for Determining the Protein Ptx3 and Kit for Said Determination |
| 10/23/2008 | US20080261245 Antibodies, including fv molecules, and immunoconjugates having high binding affinity for mesothelin and methods for their use |
| 10/23/2008 | US20080261237 Inositol-Phosphate Derivatives and Method of Detecting Inositol-1-Phosphate |
| 10/23/2008 | US20080261236 FGF21 upregulates expression of GLUT-1 in a beta Klotho-dependent manner |
| 10/23/2008 | US20080261232 Use of Precursors of Enkephalins and/or Their Fragments in Medical Diagnostics |
| 10/23/2008 | US20080261228 Using prostate cancer antigen (PCA) expression as evaluative tool in diagnosis/prognosis of cancer |
| 10/23/2008 | US20080261224 PGC-1Beta, A Novel PGC-1 Homologue and Uses Therefor |
| 10/23/2008 | US20080261223 Aldo-keto reductase specific immunoglobulin for use in diagnosis, classification and imaging of cell proliferative disorders |
| 10/23/2008 | US20080261197 O retroviral protein for use as tool in detection, treatment and prevention of human immunodeficiency virus infection |
| 10/23/2008 | US20080260830 suitable for regeneration, growth stimulation and differentiation of various cells, tissues and organs; growth/differentiation factors (GDFs); regeneration of connective tissue including tendon and/or ligament, periodontal or dental tissue including dental implants, neural tissue and sensory tissues |
| 10/23/2008 | US20080260812 Therapeutic Medicine Containing Monoclonal Antibody Against Folate Receptor Beta (Fr-Beta) |
| 10/23/2008 | US20080260768 Streptococcus pneumoniae proteins and nucleic acid molecules |
| 10/23/2008 | US20080260767 Novel Protein Which can be Used, in Particular, for the In Vitro Isolation and Prevention of Legionella Pneumophila Infections |
| 10/23/2008 | US20080260764 Variation in viral replication peptide as evaluative tool in predicting virulence in emerging influenza strains |
| 10/23/2008 | US20080260761 Compositions, Splice Variants and Methods Relating to Cancer Specific Genes and Proteins |
| 10/23/2008 | US20080260759 Novel Mite Allergen |
| 10/23/2008 | US20080260757 Bispecific Fusion Antibodies With Enhanced Serum Half-Life |
| 10/23/2008 | US20080260755 Therapeutic fusion protein in which coagulation factor sequences are fused to half-life enhancing polypeptide for use in treatment of hemophilia |
| 10/23/2008 | US20080260751 Using activator of toll like receptor-4 protein as therapeutic in treatment and prevention of arthritic, inflammatory, kidney, skin bone, respiratory, brain, cell proliferative and liver disorders |
| 10/23/2008 | US20080260750 Polynucleotides Encoding Acetylcholine-Gated Chloride Channel Subunits of Caenorhabditis Elegans |
| 10/23/2008 | US20080260748 Desmocollin 2 (DSC2) specific immunoglobulin for use in prevention and treatment of cell proliferative disorders |
| 10/23/2008 | US20080260747 Adhesion interaction protein (CD-84) specific immunoglobulin for use in the treatment of cell proliferative disorders of the blood |
| 10/23/2008 | US20080260746 Erythropoietin polypeptide for use in treatment and prevention of viral, skin, nervous system, autoimmune, cardiovascular, kidney, cell proliferative and cardiovascular disorders |
| 10/23/2008 | US20080260745 Targeted identification of immunogenic peptides |
| 10/23/2008 | US20080260743 Means and Methods for Detecting Methylated Dna |
| 10/23/2008 | US20080260742 Preventives/Remedies for Cancer |
| 10/23/2008 | US20080260741 Preventive and/or Therapeutic Agent for Cancer |
| 10/23/2008 | US20080260740 Anti-LFL2 Antibodies for the Diagnosis, Prognosis and Treatment of Cancer |
| 10/23/2008 | US20080260739 Use of Anti-Mortalin 2 Antibody and Functional Nucleic Acid for Cancer Therapies |
| 10/23/2008 | US20080260738 Single chain fc, methods of making and methods of treatment |
| 10/23/2008 | US20080260735 Glycoprotein-340 for use in targeted destruction of cancer tissues; immunotherapy |
| 10/23/2008 | US20080260734 Compositions and methods for characterizing, regulating, diagnosing, and treating cancer |
| 10/23/2008 | US20080260733 Humanized collagen antibodies and related methods |
| 10/23/2008 | US20080260732 Integrin specific immunoglobulin for inhibiting vascularization and treating cell proliferative disorders |
| 10/23/2008 | US20080260731 Fc gamma RIIIa receptor specific immunoglobulin comprising reduced fucose mdoification for use in treatment and prevention of cell proliferative and autoimmune diseases |
| 10/23/2008 | US20080260730 Using cytokine specific immunoglobulin for treatment and prevention of inflammatory, skin and autoimmune disorders |
| 10/23/2008 | US20080260729 Using RNA interference and/or endothelial growth factor specific immunoglobulins to target, treat and prevent cell proliferative disorsders |
| 10/23/2008 | US20080260727 Modulation of Nkg2d |
| 10/23/2008 | US20080260726 Using cathepsin C gene expression as evaluative tool in identifying modulators for prevention and treatment of inflammatory or obstructive diseases of the respiratory system |
| 10/23/2008 | US20080260723 Method of Treatment and Bioassay Involving Macrophage Migration Inhibitory Factor (MIF) as Cardiac-Derived Myocardial Depressant Factor |
| 10/23/2008 | US20080260721 Nucleotide sequences coding regulatory-associated protein of mTOR (Raptor) protein for use in identifying modulators for prevention and treatment of cancer and diabetes |
| 10/23/2008 | US20080260718 Phospholipase C Gamma Modulation and Uses Thereof for Management of Pain and Nociception |
| 10/23/2008 | US20080260713 Neukinase, A Downstream protein of neuregulin |
| 10/23/2008 | US20080260687 Identifying modulators which interfere with interleukin-6 and interleukin-6 receptor binding; antitumor agents; treating cell proliferative disorders |
| 10/23/2008 | US20080260641 Isolated human monoclonal antibodies which bind to lymphocyte function associated antigens; therapy and diagnosis methods; skin disorders; antiarthritic agents; inflammatory bowel disease |
| 10/23/2008 | US20080260640 Use of Precursors Of Tachykinins and/or Their Fragments in Medical Diagnostic |
| 10/23/2008 | US20080260635 Mediation of cytotoxicity of tumor cells; using cancer disease modifying antibodies and drugs; initiating cytotoxic response; binding analysis |
| 10/23/2008 | CA2718573A1 Targeting abcb5 for cancer therapy |
| 10/23/2008 | CA2688693A1 Interferons of rhesus and cynomolgus origin and uses thereof |
| 10/23/2008 | CA2684392A1 Milk derived antigen specific antibodies, methods of preparation and uses thereof |
| 10/23/2008 | CA2683911A1 Immunoassay for quantification of an unstable antigen selected from bnp and probnp |
| 10/23/2008 | CA2683778A1 Prevention of staphylococcus biofilm formation |
| 10/23/2008 | CA2682774A1 Ig-pconsensus gene vaccination protects from antibody-dependent immune pathology in autoimmune disease |
| 10/23/2008 | CA2682350A1 Diagnosis and treatment of diseases caused by misfolded proteins |
| 10/23/2008 | CA2681428A1 Molecules and methods for modulating proprotein convertase subtilisin/kexin type 9 (pcsk9) |
| 10/23/2008 | CA2662701A1 Interleukin-13 binding proteins |
| 10/23/2008 | CA2648864A1 Gene defects and mutant alk kinase in human solid tumors |
| 10/22/2008 | EP1983055A1 Albumin fusion proteins |
| 10/22/2008 | EP1983003A2 Tyrosine phosphorylation sites and antibodies specific for them |
| 10/22/2008 | EP1983002A2 Tyrosine phosphorylation sites and antibodies specific for them |
| 10/22/2008 | EP1983001A2 Antibodies to mammalian Langerhans cell antigen and their uses |
| 10/22/2008 | EP1983000A2 Method for the treatment of multiple sclerosis by inhibiting IL-17 activity |
| 10/22/2008 | EP1982999A1 Milk derived antigen specific antibodies, methods of preparation and uses thereof |
| 10/22/2008 | EP1981981A1 Anti-met monoclonal antibody, fragments and vectors thereof, for the treatment of tumors and corresponding products |
| 10/22/2008 | EP1981968A2 Non-human primate embryonic stem and germ cells: methods of use and methods of making same |
| 10/22/2008 | EP1981913A2 Antibodies that bind par-2 |
| 10/22/2008 | EP1981912A2 Antibodies against thymic stromal lymphopoietin receptor for treating allergic diseases |
| 10/22/2008 | EP1981911A2 Synergistic compositions for treating hiv |
| 10/22/2008 | EP1981909A2 Antigenic gm-csf peptides and antibodies to gm-csf |
| 10/22/2008 | EP1981902A2 Nogo receptor antagonists |
| 10/22/2008 | EP1981539A1 Treatment of metastatic breast cancer |
| 10/22/2008 | EP1981538A2 Metalloproteinase binding proteins |
| 10/22/2008 | EP1981527A2 Thermally-targeted delivery of medicaments, including doxorubicin |
| 10/22/2008 | EP1857117A4 Agent for stimulating the production of a blood coagulation factor viii |
| 10/22/2008 | EP1709448B1 Improved method for diagnosing acute coronary syndrome |
| 10/22/2008 | EP1552848B1 Compositions against chicken coccidiosis |
| 10/22/2008 | EP1532177B1 Immunomodulatory constructs and their uses |
| 10/22/2008 | EP1375518B1 Anti-osteopontin antibody and use thereof |
| 10/22/2008 | EP1311679B1 Method for inhibiting il-22 induced pap1 |
| 10/22/2008 | EP1017725B1 Method of affinity cross-linking biologically active, immunogenic peptides to antibodies |
| 10/22/2008 | EP0833941B1 Polypeptides having a functional domain of interest and methods of identifying and using same |
| 10/22/2008 | EP0817835B1 Production of antibodies using cre-mediated site-specific recombination |
| 10/22/2008 | EP0742825B1 Cloning and recombinant production of crf receptor(s) |
| 10/22/2008 | CN101292042A Cancerous desease modifying antibodies |
| 10/22/2008 | CN101292041A Cancerous desease modifying antibodies |
| 10/22/2008 | CN101292031A Nato3 markers of growing progenitor cell of dopamine-producing neuron |
| 10/22/2008 | CN101292030A Msx1/2 markers of growing progenitor cell of dopamine-producing neuron |
| 10/22/2008 | CN101291954A Modified antigen binding molecules with altered cell signaling activity |
| 10/22/2008 | CN101291693A Novel use of il-1beta compounds |
| 10/22/2008 | CN101289512A Method for the high level expression of active lymphotoxin-beta receptor immunoglobulin chimeric proteins and their purification |